mafalda t. soares md, inês delgado md, teresa gabriel md ... · • bezerra tf, padua fg, pilan...
Post on 13-Feb-2019
212 Views
Preview:
TRANSCRIPT
• Goode RL. Diagnosis and Treatment of
Turbinate Dysfunction: A Self-Instructional
Package. American Academy of
Otolaryngology-Head and Neck Surgery
Foundation, Inc.; 1977.;
• Harrill WC, Pillsbury HC 3rd, McGuirt WF,
Stewart MG. Radiofrequency turbinate
reduction: a NOSE evaluation.
Laryngoscope. 2007 Nov;117(11):1912-9.;
• Cavaliere M, Mottola G, Iemma M.
Comparison of the effectiveness and safety
of radiofrequency turbinoplasty and
traditional surgical technique in treatment of
inferior turbinate hypertrophy. Otolaryngol
Head Neck Surg. 2005 Dec;133(6):972-8.
• Coste A, Yona L, Blumen M, et al.
Radiofrequency is a safe and effective
treatment of turbinate hypertrophy.
Laryngoscope. May 2001;111(5):894-9. ;
• Hytönen ML, Bäck LJ, Malmivaara AV,
Roine RP. Radiofrequency thermal ablation
for patients with nasal symptoms: a
systematic review of effectiveness and
complications. Eur Arch Otorhinolaryngol.
Aug 2009;266(8):1257-66.;
• Bezerra TF, Padua FG, Pilan RR, Stewart
MG, Voegels RL. Cross-cultural adaptation
and validation of a quality of life
questionnaire: the Nasal Obstruction
Symptom Evaluation questionnaire.
Rhinology. 2011 Jun;49(2):227-31
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
Before
RFTR
After
RFTR
n=32
Patient’s impact in quality of life (%)
Quality of Life after Radiofrequency Turbinate Reduction
Mafalda T. Soares MD, Inês Delgado MD, Teresa Gabriel MD, Ana Guimarães MD, Pedro Henriques MD, Filipe Freire MD
Prof. Doutor Fernando Fonseca Hospital
Amadora, Portugal
INTRODUCTION
RESULTS/DISCUSSION
ABSTRACT METHODS AND MATERIALS
CONCLUSIONS
REFERENCES
Inferior turbinate hypertrophy is
one of the major causes of nasal
airway obstruction causing
significant impact on quality of life.
Using the Nasal Obstruction
Symptom Evaluation
questionnaire Portuguese version
(NOSE-p), the authors
prospectively analyzed the
outcomes in the quality of life of
patients with inferior turbinate
hypertrophy that underwent
isolated RFTR in our department.
The NOSE-p scores were
obtained before surgery and at 1
month follow-up. In 87,5%
of patients the NOSE–p score
before surgery was greater than
70%.
Our data demonstrated significant
improvement from baseline after 1
month in 90,6% of patients.
Therefore, we can conclude that
RFTR remains a safe and efficient
treatment for patients with nasal
obstruction related to inferior
turbinate hypertrophy.
• Our sample was composed of 32 patients:
• 23 females and 9 males. (chart 1)
• The mean age was 36 years old. (chart 2)
• 75% of patients referred symptoms of allergic rhinitis. (chart 3)
• There were no complications related to the
procedure.
• The NOSE-p questionnaire was applied before
surgery and 1 month after surgery. In 87,5%
of patients the NOSE–p score before surgery was
greater than 70%. (chart 4)
• Our data demonstrated significant improvement from
baseline after 1 month in 90,6% of patients. (chart 4)
Using NOSE-p the authors prospectively
analyzed the outcomes in the quality of life of
patients with inferior turbinate hypertrophy that
underwent isolated RFTR in our department in
2014 (fig.1). The NOSE-p scores were obtained
before surgery and at 1 month follow-up.
• CelonProBreath® bipolar electrode 1.1 mm
diameter (fig.2&3)
• Exclusion criteria: patients submitted to other
surgical procedures
The NOSE-p questionnaire showed a great
improvement in the quality of life of patients
that underwent RFTR.
There weren’t complications related to the
procedure. Therefore, we can conclude that
RFTR remains a safe and efficient treatment
for patients with nasal obstruction related to
inferior turbinate hypertrophy.
Inferior turbinate hypertrophy is one of the
major causes of nasal airway obstruction
causing significant impact on quality of life.
Radiofrequency turbinate reduction (RFTR) is
a minimally invasive surgical option that uses
low-power radiofrequency energy within the
submucosal tissue of the turbinate, reducing
tissue volume with minimal impact on
surrounding tissues. The Nasal Obstruction
Symptom Evaluation (NOSE) instrument is a
disease-specific questionnaire for assessing
the outcome of an intervention in nasal
obstruction. A validation of this questionnaire
was made for Portuguese language by
Bezerra et al. (NOSE-p).
Mafalda Trindade Soares, MD
Email: mafaldamctsoares@gmail.com
OUTCOME OBJECTIVES
Analyze the impact in quality of life and safety
of Radiofrequency turbinate reduction (RFTR)
in patients with inferior turbinate hypertrophy.
Males 31%
Females 69%
0
2
4
6
8
10
12
14
≤ 25 years 26-45 years 46-65 years ≥ 65 years
Nº patients
n=32
n=32
Allergic
Rhinitis
75%
25%
n=32
Chart 1. Sex
Chart 3. Allergic Rhinitis
Chart 2. Age
Chart 4. Quality of life (NOSE-p scores) before and after RFTR
Figure 2 & 3. CelonProBreath® bipolar electrode 1.1 mm diameter
Figure 1. Nasal Obstruction Symptom Evaluation portuguese version: Nose-p
top related